1.
PPR group (n=43) | CS group (n=58) | Test value | P | |
PPR: preoperative pulmonary rehabilitation; CS: conventional scheme; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; MVV: maximum ventilatory volume; PEF: peak expiratory flow; COPD: chronic obstructive pulmonary disease; RUL: right upper lobe; RML: right middle lobe; RLL: right lower lobe; RU-ML: right upper middle lobe; RM-LL: right middle lower lobe; LUL: left upper lobe; LLL: left lower lobe; SC: squamous carcinoma; AC: adenocarcinoma. | ||||
Age (Mean±SD, yr) | 58.9±8.9 | 61.1±9.1 | t=0.308 | 0.580 |
Gender | χ2=0.117 | 0.733 | ||
Male | 26 | 37 | ||
Female | 17 | 21 | ||
Pulmonary function | ||||
FEV1 (L) | 2.06±0.45 | 2.16±0.47 | t=1.074 | 0.285 |
FVC (L) | 3.16±0.68 | 3.27±0.68 | t=0.830 | 0.409 |
PEF (L/s) | 4.32±0.90 | 4.51±0.99 | t=0.946 | 0.346 |
MVV (L/min) | 86.69±16.56 | 90.59±15.60 | t=1.210 | 0.229 |
Severity of COPD | χ2=0.117 | 0.494 | ||
Mild | 30 | 44 | ||
Moderate to severe | 13 | 14 | ||
Resection range | χ2=3.173 | 0.787 | ||
RUL | 18 | 27 | ||
RML | 2 | 1 | ||
RLL | 8 | 9 | ||
RU-ML | 0 | 1 | ||
RM-LL | 1 | 0 | ||
LUL | 7 | 11 | ||
LLL | 7 | 9 | ||
Pathology | χ2=0.218 | 0.897 | ||
SC | 16 | 19 | ||
AC | 25 | 36 | ||
Other types | 2 | 3 | ||
Pathological stage | χ2=1.576 | 0.455 | ||
Stage Ⅰ | 21 | 32 | ||
Stage Ⅱ | 11 | 17 | ||
Stage Ⅲ | 11 | 9 | ||
Stage Ⅳ | 0 | 0 |